Patent expirations of one HIV drugs will make the disease cheaper—but also more cumbersome—to treat.
The Scientist
Most Recent
A researcher from the John Wayne Cancer Institute has settled his scientific misconduct case with the Office of Research Integrity.
Lymphatic vessels grow towards two chemokines, revealing signals that could be important in cancer metastasis.
Like commensal gut organisms, skin microbiota appear to help the mammalian immune system mature and stay regulated.
An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.
The FDA approves the use of Truvada for those at high risk of HIV infection.
Present in every tissue of the body, ubiquitin appears to be involved in a dizzying array of functions, from cell cycle and division to organelle and ribosome biogenesis, as well as the response to viral infection. The protein plays at least two role
Sensitive tests reveal the Berlin patient believed to be cured of HIV still carries HIV RNA and antibodies.
Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.
New computational modeling suggests pre-existing HIV drug resistance mutations may contribute more to drug failure than previously thought.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
